US Patent Issued on May 20 for "Therapeutic methods using bupropion hydrobromide to treat Major Depressive Disorder" (New York Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,473, issued on May 20.

"Therapeutic methods using bupropion hydrobromide to treat Major Depressive Disorder" was invented by Richard Louis Price (Suffern, N.Y.) and Maxwell Zachary Price (Suffern, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods of treating a patient having Major Depressive Disorder (MDD). The methods include administering to the patient a therapeutically effective amount of bupropion hydrobromide in extended-release form. The methods are more therapeutically effective in treating MDD than administration of an equivalent plasma dose of bupropion hydrochloride in extended-release form. Optionally, in addition...